On Friday, H.C. Wainwright adjusted its stock price target for Vertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ:VRTX), reducing it from $600.00 to $535.00, while retaining a Buy rating on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results